Surveillance of adverse events following vaccination in the French armed forces, 2011–2012
| Autor: | S. Duron, J.-L. Koeck, Jean-Baptiste Meynard, R. Migliani, Xavier Deparis, A. Mayet |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male medicine.medical_specialty Pediatrics Drug-Related Side Effects and Adverse Reactions Vaccination schedule Meningococcal Vaccines Meningococcal vaccine Young Adult Epidemiology Product Surveillance Postmarketing medicine Adverse Drug Reaction Reporting Systems Humans Vaccines Combined Young adult Adverse effect Diphtheria-Tetanus-Pertussis Vaccine Immunization Schedule Vaccines Vaccines Conjugate business.industry Public Health Environmental and Occupational Health General Medicine Middle Aged Surgery Vaccination Poliovirus Vaccine Inactivated Military personnel Military Personnel BCG Vaccine Female France business BCG vaccine |
| Zdroj: | Public Health. 129:763-768 |
| ISSN: | 0033-3506 |
| DOI: | 10.1016/j.puhe.2015.03.003 |
| Popis: | Objectives French military personnel are subject to a compulsory vaccination schedule. The aim of this study was to present the results of surveillance of vaccine adverse events (VAEs) reported from 2011 to 2012 in the French armed forces. Study design VAEs were surveyed among all French armed forces from 2011 to 2012 by the epidemiological departments of the military health service. For each case, a notification form providing patient and clinical information was provided. Methods Case definitions were derived from the French drug safety guidelines. Three types of VAE were considered: non-serious, serious and unexpected. Incidence rates were calculated by relating VAEs to the number of vaccine doses delivered. Results In total, 161 VAE cases were reported. The overall VAE reporting rate was 24.6 VAEs per 100,000 doses, and the serious VAE rate was 1.3 per 100,000 doses (nine cases). The serious VAEs included two cases of Guillain-Barre syndrome, one case of optic neuritis, one case of a meningeal-like syndrome, one case of rheumatoid purpura, one case of acute asthma and three cases of fainting. The highest rates of VAE were observed with the Bacille Calmette–Guerin vaccine (BCG) (482.3 per 100,000 doses), inactivated diphtheria–tetanus–poliovirus with acellular pertussis vaccine (dTap-IPV) (106.1 per 100,000 doses) and meningococcal quadrivalent glycoconjugate vaccine (MenACWY-CRM) (39.3 per 100,000 doses). Conclusions The global rates of VAE observed in 2011 and 2012 confirm the increase that has been observed since 2009 in the French armed forces, which could reflect improved practitioner awareness about VAEs and the use of certain vaccines added to the vaccination schedule recently (dTap-IPV in 2008 and MenACWY-CRM in 2010). VAEs appear to be relatively rare, particularly serious VAEs, which indicates acceptable tolerance of vaccines. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect